7 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... for Treatment & ... • Giant Cell Arteritis ... arteritis (TAK) ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... (GCA) - Vasculitis ... Management Algorithm ... #Management #Treatment ... #algorithm #rheumatology
Anterior ischemic optic neuropathy (AION) - Recognition of giant cell arteritis (GCA)

1) Is visual loss caused
of giant cell arteritis ... visual loss caused ... Clinical manifestations ... #Rheumatology # ... Ophthalmology #Diagnosis #Algorithm
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #algorithm #rheumatology
Giant cell arteritis (GCA)

Giant cell arteritis (GCA) definition: Most common systemic inflammatory vasculitis in older adults
arteritis (GCA) ... Diagnosis = clinical ... identifies 85 to 95% of cases ... of the steroid treatment ... Treatment of GCA
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
if they have no clinical ... 15,000/mm3, and urine ... purposes of this algorithm ... ≥2.5, coronary arteries ... echo is positive, treatment
Polymyalgia Rheumatica (PMR) Diagnosis and Management Summary

WHAT?
 • Polymyalgia rheumatica (PMR) is a common systemic inflammatory
disease of unknown cause ... CLINICAL: • Physical ... for giant cell arteritis ... TREATMENT: • The ... mainstay of treatment